<i><scp>MYD</scp>88</i> wild‐type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival
Steven P. Treon(Dana-Farber Cancer Institute), Jorge J. Castillo(Dana-Farber Cancer Institute), Christopher J. Patterson(Dana-Farber Cancer Institute), Amanda Kofides(Shaanxi Research Association for Women and Family), Gloria Chan(Shaanxi Research Association for Women and Family), Maria Demos(Shaanxi Research Association for Women and Family), Nicholas Tsakmaklis(Shaanxi Research Association for Women and Family), Xia Liu(Shaanxi Research Association for Women and Family), Maria Luisa Guerrera(Harvard University), Manit Munshi(Dana-Farber Cancer Institute), Joshua Gustine(Boston University), Robert Manning(Harvard University), Kirsten Meid(Shaanxi Research Association for Women and Family), Patricia Severns(Harvard University), Toni Dubeau(Shaanxi Research Association for Women and Family), Guang Yang(Blueprint Medicines (United States)), Lian Xu(Huazhong Agricultural University), Jiaji Chen(Harvard University), Zachary R. Hunter(Harvard University)
Cited by 105
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
|Blood|2001|905
Immunopathology of Hyperinflammation in COVID-19
|American Journal Of Pathology|2020|526
Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders
|Clinical Infectious Diseases|2006|270
ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer
|Nature Communications|2021|265